Monday, June 08, 2020 8:42:48 AM
Wow! Can't believe I still see this kind of fluffy news right from the company! This is not a news I have been expecting for! Still forward looking statements one after another! What's a joke! No wonder why ppd is not going anywhere.
Oh it seems Symtomax doesn't really have the Oraltabs market in place yet!
Quote:
Symtomax has sourced numerous retail outlets and pharmacies for the distribution of the product, and is in further discussions with major distributors in a number of European countries such as the UK, Germany, Gibraltar and Portugal, as well as South Africa and Brazil.
This is a joke now! Hey JMO.
Oh it seems Symtomax doesn't really have the Oraltabs market in place yet!
Quote:
Symtomax has sourced numerous retail outlets and pharmacies for the distribution of the product, and is in further discussions with major distributors in a number of European countries such as the UK, Germany, Gibraltar and Portugal, as well as South Africa and Brazil.
This is a joke now! Hey JMO.
Recent GCAN News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:22:05 PM
- GCANRx Announces Relisting To OTCQB Market Tier • GlobeNewswire Inc. • 12/03/2025 12:45:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/16/2025 03:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2025 11:00:32 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 02:05:11 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/08/2025 01:56:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 03:57:40 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 05/06/2025 12:54:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/05/2025 10:09:45 AM
